Discussion
In our recent study, RATS were performed in 93 children with PS over 6 months old and more than 7.0 kg. RATS was a safe and feasible approach with notable short-time postoperative outcome than which in VATS.
RATS started relatively late in the field of pediatrics, and the number of operations carried out in children is much lower than in adults. Navarrete Arellano and Garibay González reported 6 cases of RATS from 2015 to 2018, including 3 cases of diaphragm folding, 2 cases of lobectomy, and 1 case of bronchial cyst resection.7 Durand et al. reported seven cases of robotic lobectomy for bronchiectasis in children.8 Meehan and Sandler documented 11 cases of RATS, including 4 cases of lung surgery, with only 1 case involving ILS.9 The present study confirmed the efficacy of RATS in children with PS.
To date, there is no global consensus on the choice of the minimum age for RATS. The use of robotic systems needs a certain amount of space between the arms (typically 8 cm), which may limit patients who are too young. Denning et al. noted that the size of robotic instruments could be prohibitively large for the ICS of a child weighing 5 kg or less.10 Molinaro et al. conducted a retrospective analysis of RATS and considered a weight above 7.0 kg to be appropriate for RATS.11 Ballouhey et al. reported two cases with esophageal atresia (weight 3.0 and 3.1 kg, respectively) performed RATS; however, eventually they were converted to thoracotomy.12 Meehan et al. performed four cases of robot-assisted lobectomy in infants with congenital cystic adenomatoid malformation or PS.4 9 The average age of these infants was 7 months, with an average body weight of 7.9 kg. They also planned to perform RATS on a newborn weighing 2.5 kg with diaphragmatic hernia but opted for VATS due to the small size of chest.9 Our study established criteria for RATS as being over 6 months old and having a minimum weight of 7.0 kg. Furthermore, there is currently no international consensus regarding the optimal age for surgery for PS. Children with asymptomatic sequestration are particularly susceptible to developing pulmonary infections and abscesses, especially with ILS.13 As the infection rate of PS significantly increased with age, performing surgery becomes more challenging, resulting in longer operative time, increased intraoperative bleeding, and extended hospital stays. Given that most complications manifest within the first year of life, 6 and 12 months of age became to be a preferred range of age.2 14 15
Compared with the more flexible approach for the placement of a 5 mm trocar in VATS, RATS requires stricter discipline for each port and docking. The da Vinci surgical system recommends that the distance between each trocar should be approximately 8 cm. However, based on reported experiences by Ballouhey et al., a distance of approximately 5 cm is also feasible.16 The robotic port placement was adjusted based on the operation experience, ensuring that each arm would not interfere with the small chest. The overall arrangement was fan shaped, similar to the adult procedure.17 Durand et al. also reported a ‘W modified’ shape.8 In addition, there is a very special type of ELS, in which the PS is located in the diaphragm. In that case, the placement of the four ports is quite different from the usual procedure which was described in our previous reports.18 The assistant stood at the head side of the patient. The robot located at the back side of the patient’s abdomen. The diaphragm was dissected to explore the tissue of PS. After the intradiaphragmatic lesion was removed, the diaphragm was sutured to prevent iatrogenic diaphragmatic hernia. We had previously reported 10 cases of intradiaphragmatic ELS treated by RATS,18 which were not included in this study.
The conversion rate of robotic lobectomy was 4.7%–9.2% in adults, with the main reasons being bleeding and adhesion. Due to anatomical reasons, the conversion rate of upper lobectomy was relatively high, up to 17.5%.19–21 Although the conversion rate of robotic lobectomy in adults was reported to be lower than that of VATS,22 no significant difference in ratio of conversion between the two groups and no surgical death in either group were shown in our study, indicating the safety of the RATS was similar with VATS. Previous studies showed that the overall conversion rate of robotic surgery in pediatric patients is 2.5%–4.7%, regardless of the operative site.7 23 Moreover, Cundy et al. showed that the conversion rate of robotic thoracic surgery in children was approximately 10%.23 Durand et al. reported on 18 children with bronchiectasis,8 including 7 cases treated with RATS and 11 cases with VATS, and noted that there was no conversion in the RATS group and 5 in the VATS group. In our study, one surgical conversion occurred in each group and both occurred during lobectomy procedures. There was also no significant difference of conversion between the lobectomy subgroup, which may be related to the small sample size of each subgroup. In the VATS group, a 4-year-old patient with ILS suffered conversion because of severe pleural adhesion and bleeding due to preoperative recurrent infections. Although preoperative pulmonary infection was considered to be the crucial factor for conversion, we believe that effective single-lung ventilation is another important factor for both types of surgery. In the RATS group, a 7-month-old patient with ILS suffered conversion due to displacement of the bronchus blocker and failure of single-lung ventilation in the process of dissecting the bronchia. The short length of bronchi and the lack of proper bronchial blockers made it challenging to perform satisfactory single-lung ventilation in pediatric patients, especially in low-weight patients.
Among the lobectomy subgroup, the operation time was significantly longer in the RATS group than the VATS group. These results were similar to Durand et al.’s study in which the median operative time of lobectomy was significantly longer in RATS than in VATS (268 (221.5–286.5) min vs. 131 (115.5–190.0) min, p=0.004).8 Due to the higher proportion of preoperative infections, such as infected congenital pulmonary malformations, primary ciliary dyskinesia, and postviral infections, the operation time in their study was longer than ours. In addition, we timed the installation and withdrawal procedures separately. The installation time was within 5–10 min, and the withdrawal time was within 3–5 min. Therefore, we attributed the extra time primarily to the replacement of robotic instruments during the operation. Similar evidence has shown that there is no significant difference in the pure operative time between the two groups when excluding the instrument replacement time and docking time.24
In our study, RATS demonstrated superior efficiency in short-time postoperative outcomes compared with VATS, including ratio of chest tube indwelling, chest tube duration, and postoperative duration. The increased df and enhanced dexterity in RATS improved the dissection of anomalous vessels and lesions as well as executing hemostasis more effectively, which may be a potential reason for the reduction of chest tube indwelling ratio and drainage duration. These findings suggest that RATS offers advantages in specific postoperative outcomes despite longer duration of operation, highlighting its potential as a favorable treatment option for pediatric patients with PS. Additionally, as a novel technology, RATS did not increase the conversion rate or postoperative short-term complications compared with VATS.
RATS also presented certain limitations, such as increased surgery cost. However, the reduction in hospitalization duration and overall nursing care costs partially offset the additional financial burden associated with implementing robotic surgery.21 Rowe et al. found that robotic surgery resulted in an 11.90% reduction in direct expenses, mostly due to shorter hospitalization, and assumed that increased surgical volume and a competitive market might potentially reduce robotic surgery costs.25 A recent study suggested that once a hospital performs 25 or more pulmonary surgeries, the costs of RATS and VATS become equivalent.26 Concerning surgical incisions, RATS required larger incisions to accommodate an 8 mm trocar and an additional incision compared with VATS. To mitigate scar formation, tension-reduction sutures were used and no noticeable visual difference in incision length was observed between the two groups. Li et al. reported the scar scores showed no significant differences when assessed 3 months after operation.24 Instruments of appropriate size for children in robotic system are expected. Recently, 3 mm-sized instruments for robotic systems have been developed which might be particularly suitable for the younger children and neonates.27
In this study, RATS showed better short-time postoperative outcomes compared with VATS. However, further accurate studies are needed to evaluate the long-term benefits of RATS. Furthermore, this is a single-center study by one surgeon and more multi-institutional clinical studies are warranted to explore the differences between RATS and VATS.
In conclusion, although there were limitations in the application of RATS in younger, low-weight infants, our study demonstrates that RATS is a feasible and safe approach with notable advantages in short-term postoperative outcomes for pediatric patients with PS over 6 months and more than 7 kg in weight. However, the benefits of this new technique over traditional thoracoscopic approaches need to be thoroughly assessed through further robust prospective investigations.